Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
This is a phase 1 study evaluating the safety and maximum tolerated dose of Liothyronine (T3) in subjects with multiple sclerosis
Epistemonikos ID: 8bb5ad86c082d229ee52b3d0d1469376a9597b75
First added on: Mar 31, 2022